The largest database of trusted experimental protocols

Rabbit anti s2 antibody

Manufactured by Sino Biological

Rabbit anti-S2 antibody is a primary antibody that specifically recognizes the S2 subunit of the SARS-CoV-2 spike protein. It is produced in rabbits and can be used for various research applications, such as ELISA, Western blot, and immunohistochemistry.

Automatically generated - may contain errors

2 protocols using rabbit anti s2 antibody

1

Characterization of SARS-CoV-2 S Glycoprotein

Check if the same lab product or an alternative is used in the 5 most similar protocols
293T-S cells express the wild-type S glycoprotein from a SARS-CoV-2 Wuhan-Hu-1 strain (Nguyen et al., 2021 ). 293T-S cells were seeded in 6-well plates at a density of 1×106 cells per well on day 0. On day 1, cells were either induced with 1 μg/ml doxycycline or mock treated as a control. Two days after induction, cells were lysed with lysis buffer (1× PBS, 1% NP-40, 1× protease inhibitor cocktail (Roche)). Cell lysates were subjected to Western blotting using the CV3–1 or CV3–25 antibodies; mouse anti-S1 antibody (Sino Biological) and rabbit anti-S2 antibody (Sino Biological) were used as controls. The Western blots were developed with horseradish peroxidase (HRP)-conjugated secondary antibodies (anti-human IgG, anti-mouse IgG or anti-rabbit IgG, correspondingly). To evaluate antibody recognition of S glycoproteins lacking N-linked glycans, 293T-S cells expressing the wild-type SARS-CoV-2 S glycoprotein were lysed with lysis buffer, as described above. Lysates were treated with PNGase F (NEB) following the manufacturer’s instructions or mock treated as a control. The lysates were then Western blotted with the CV3–25 antibody, as described above.
+ Open protocol
+ Expand
2

Characterization of SARS-CoV-2 S Glycoprotein

Check if the same lab product or an alternative is used in the 5 most similar protocols
293T-S cells express the wild-type S glycoprotein from a SARS-CoV-2 Wuhan-Hu-1 strain (Nguyen et al., 2021 ). 293T-S cells were seeded in 6-well plates at a density of 1×106 cells per well on day 0. On day 1, cells were either induced with 1 μg/mL doxycycline or mock treated as a control. Two days after induction, cells were lysed with lysis buffer (1x PBS, 1% NP-40, 1x protease inhibitor cocktail [Roche]). Cell lysates were subjected to Western blotting using the CV3-1 or CV3-25 antibodies; mouse anti-S1 antibody (Sino Biological) and rabbit anti-S2 antibody (Sino Biological) were used as controls. The Western blots were developed with horseradish peroxidase (HRP)-conjugated secondary antibodies (anti-human IgG, anti-mouse IgG or anti-rabbit IgG, correspondingly). To evaluate antibody recognition of S glycoproteins lacking N-linked glycans, 293T-S cells expressing the wild-type SARS-CoV-2 S glycoprotein were lysed with lysis buffer, as described above. Lysates were treated with PNGase F (NEB) following the manufacturer's instructions or mock treated as a control. The lysates were then Western blotted with the CV3-25 antibody, as described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!